A group of natural compounds attracting attention for their anti-aging potential has a dark side. New research shows how a ...
Morning Overview on MSN
Study links a popular anti-aging supplement pathway to faster cancer growth
Preclinical research across multiple cancer types now shows that the NAD+ salvage pathway, the same biological mechanism targeted by popular anti-aging supplements like nicotinamide mononucleotide ...
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed ...
Nanjing Leads Biolabs Co., Ltd. ('Leads Biolabs' or the 'Company,' Stock Code: 9887.HK) announced on March 6, 2026 that the ...
The biotech company secured investigational new drug clearance from US regulators to begin human testing of its GNTbm-38 ...
A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.
Cipla USA is voluntarily recalling over 400 cartons of its anti-cancer drug, Nilotinib Capsules, due to a manufacturing issue.
Researchers have found evidence of nuclear metabolic enzymes for the first time, contributing to our understanding of cancer ...
Scientists have experimented with bacteria as potential cancer therapy for a while now — some introduced to trigger an immune ...
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...
More than 200 metabolic enzymes, many of which are normally tasked with producing energy in the mitochondria, are also found ...
A receptor involved in normal physiological processes may also drive breast cancer growth when overexpressed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results